Antidepressants and mood stabilizers Flashcards
1
Q
Class of antidepressants
A
- TCA (tricyclic amides): inhibition of presynaptic reuptake of NE/5HT/DA (ex: amitriptyline)
- SSRI: inhibition of presynaptic reuptake of 5HT (ex: fluoxetine)
- MAOI: inhibition of monoamine oxidase (ex: phenelzine)
- Others: 5HT2 antagonism (mirtazapine), DA reuptake inhibitor (bupropion)
- Rx can be acute (6-8 wks), months-years (continuation or maintenance), or be lifelong (maintenance)
- Rx of antidepressants to someone w/ bipolar d/o can trigger a manic phase
2
Q
Amitriptyline (Elavil)
A
- TCA: inhibits the reuptake of NE, 5NT, and DA
- Causes sedation (inhibits histamine), dizziness (inhibits a1 adrenergic), dry mouth and constipation (inhibits cholinergic)
- Is effective and inexpensive
- Major problem: chance of cardiotoxicity/heart block in OD (need ECG baseline and to monitor)
3
Q
Fluoxetine (prozac)
A
- SSRI
- Causes nausea and diarrhea (agonist of 5HT3)
- Causes headache, sexual changes like delayed ejaculation (agonist of 5HT2)
- 30-50% have sexual side effects
- Safety in OD, does not cause sedation
4
Q
Phenelzine (Nardil)
A
- MAOI
- Causes dizziness and postural hypotension (a1 inhibition)
- Increases wakefulness and causes insomnia
- Hypertensive crisis when mixed w/ pseudoephedrine or tyramine (no aged cheese or wine)
5
Q
Mirtazapine (Remeron)
A
- 5HT2 antagonism
- No sexual side effects, nausea, or headache
- Blocks histamine but less sedation due to NE increase
- Main common adverse effect: sedation (due to blocking histamine) and significant weight gain
6
Q
Bupropion (wellbutrin)
A
- DA/NE reuptake inhibitor
- Helps in cessation of smoking and ADHD
- No sexual dysfunction, no weight gain
- Common adverse effect: insomnia, upset stomach
- Seizure risk: not used in those w/ epilepsy/seizures or those w/ eating d/o particularly bulimia
7
Q
Mood stabilizers
A
- Rx for bipolar disorder, are taken lifelong to prevent relapse of illness
- Either lithium (more lethal in OD) or valproate (less lethal in OD)
8
Q
Lithium
A
- Eskalith, lithobid
- Excreted unchanged thru renal
- Inhibits excitatory NT (NE, DA) release, enhances 5HT to help deal w/ depression
- Effective in both stages of the disease, best relapse prevention
- Onset 1-2 wks (less lipophilic), lethal in OD
- Therapeutic level: .6-1.5 mEq/L
- Drug interactions: ibuprofen, caffeine
9
Q
Valproate
A
- Depakene, Depakote
- Facilitates GABA activity, broad-spectrum anticonvulsant
- For acute mania, mixed mania (rapid cycling)
- Less established relapse prevention
- Onset 2-5 days (lipophilic), much safer in OD
- Hepatic elimination
- Therapeutic level: 50-125 mg/L